1,659 results on '"Akaza, Hideyuki"'
Search Results
102. Phase 3, randomized, placebo-controlled study of zibotentan (ZD4054) in patients with castration-resistant prostate cancer metastatic to bone
103. Analysis of Intravesical Recurrence After Bladder-preserving Therapy for Muscle-invasive Bladder Cancer
104. Phase II Study of the Safety and Efficacy of Temsirolimus in East Asian Patients with Advanced Renal Cell Carcinoma†
105. Prostate cancer chemoprevention by soy isoflavones: Role of intestinal bacteria as the “second human genome”
106. The Efficacy and Safety of Degarelix, a GnRH Antagonist: A 12-month, Multicentre, Randomized, Maintenance Dose-finding Phase II Study in Japanese Patients with Prostate Cancer
107. Prostate Cancer Chemoprevention Study: An investigative randomized control study using purified isoflavones in men with rising prostate-specific antigen
108. Proven Efficacy of Combined Androgen Depletion Therapy
109. Overall survival and good tolerability of long-term use of sorafenib after cytokine treatment: final results of a phase II trial of sorafenib in Japanese patients with metastatic renal cell carcinoma
110. The liposome-incorporating cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guéin can directly enhance the susceptibility of cancer cells to lymphokine-activated killer cells through up-regulation of natural-killer group 2, member D ligands
111. Combined Immunotherapy with Low-dose IL-2 Plus IFN-α for Metastatic Renal Cell Carcinoma: Survival Benefit for Selected Patients with Lung Metastasis and Serum Sodium Level
112. Maintenance therapy with bacillus Calmette-Guérin Connaught strain clearly prolongs recurrence-free survival following transurethral resection of bladder tumour for non-muscle-invasive bladder cancer
113. The 7th Asia Cancer Forum: From the Perspective of Human Security, How Can We Collaborate as Asians in Order to Place Cancer on the Global Health Agenda? How Can We Fill in the Gaps that Exist Among Us?
114. The 6th Asia Cancer Forum: What Should We Do to Place Cancer on the Global Health Agenda? Sharing Information Leads to Human Security
115. A Phase I Study of Personalized Peptide Vaccination Using 14 Kinds of Vaccine in Combination With Low-Dose Estramustine in HLA-A24-Positive Patients With Castration-Resistant Prostate Cancer†
116. Efficacy and Safety of Dutasteride on Prostate Cancer Risk Reduction in Asian Men: The Results from the REDUCE Study
117. Sorafenib-associated hand–foot syndrome in Japanese patients
118. APAF-1 is related to an undifferentiated state in the testicular germ cell tumor pathway
119. Combined androgen blockade for prostate cancer: Review of efficacy, safety and cost-effectiveness
120. Phase III Trial of Everolimus in Metastatic Renal Cell Carcinoma: Subgroup Analysis of Japanese Patients from RECORD-1
121. Modified J‐CAPRA scoring system in predicting treatment outcomes of metastatic prostate cancer patients undergoing androgen deprivation therapy
122. Real-world use of sorafenib for advanced renal cell carcinoma patients with cardiovascular disease: nationwide survey in Japan
123. Real-world use of temsirolimus in Japanese patients with unresectable or metastatic renal cell carcinoma: recent consideration based on the results of a post-marketing, all-case surveillance study
124. LBA02-07 HERO PHASE 3 TRIAL: RESULTS COMPARING RELUGOLIX, AN ORAL GNRH RECEPTOR ANTAGONIST, VS LEUPROLIDE ACETATE FOR ADVANCED PROSTATE CANCER
125. Extremely acute exacerbation of interstitial pneumonia after interferon-alpha treatment for metastatic renal cell carcinoma
126. Overall Survival and Updated Results from a Phase II Study of Sunitinib in Japanese Patients with Metastatic Renal Cell Carcinoma
127. Maintenance intravesical bacillus Calmette-Guérin instillation for Ta, T1 cancer and carcinoma in situ of the bladder: Randomized controlled trial by the BCG Tokyo Strain Study Group
128. What Should We Do to Raise Awareness on the Issue of Cancer in the Global Health Agenda?
129. Prostate Cancer Working Group Report
130. Current Asia Pacific Anticancer Therapy and Research Initiatives and Strategies
131. Aim of the Working Group on the Asian Perspectives on Cancer Control: Asian Perspective on Prostate Cancer Prevention
132. Noninfectious Pneumonitis after Everolimus Therapy for Advanced Renal Cell Carcinoma
133. Pattern of intravesical recurrence after surgical treatment for urothelial cancer of the upper urinary tract: A single institutional retrospective long-term follow-up study
134. Successful Outcomes Using Combination Therapy of Interleukin-2 and Interferon-α for Renal Cell Carcinoma Patients with Lung Metastasis
135. Hormonal therapy for prostate cancer: Current topics and future perspectives
136. Suppression of AhR signaling pathway is associated with the down-regulation of UDP-glucuronosyltransferases during BBN-induced urinary bladder carcinogenesis in mice
137. Successful Management by Provocative Angiography and Endovascular Stent of Ureteroarterial Fistula in a Patient with a Long-term Indwelling Ureteral Stent
138. A Phase II Study of Sunitinib in Japanese Patients with Metastatic Renal Cell Carcinoma: Insights into the Treatment, Efficacy and Safety
139. Current status of chemotherapy in risk-adapted management for metastatic testicular germ cell cancer
140. Cavernous hemangioma mimicking a cystic renal cell carcinoma
141. Low expression of microphthalmia-associated transcription factor, a potential molecular target for interferon-alpha susceptibility, is associated with metastasis in renal cell carcinoma
142. Combined androgen blockade with bicalutamide for advanced prostate cancer: Long-Term Follow-Up of a Phase 3, Double-Blind, Randomized Study for Survival
143. Real-time Elastography for the Diagnosis of Prostate Cancer: Evaluation of Elastographic Moving Images
144. Immunoprotection against murine bladder carcinoma by octaarginine-modified liposomes incorporating cell wall of Mycobacterium bovis bacillus Calmette-Guérin
145. Bladder cancer develops 6 years earlier in current smokers: Analysis of bladder cancer registry data collected by the cancer registration committee of the Japanese Urological Association
146. EFFECT OF BASIC FIBROBLAST GROWTH FACTOR INCORPORATING GELATIN MICROSPHERES ON ERECTILE FUNCTION IN THE DIABETIC RAT
147. NOMOGRAMS INCLUDING NUCLEAR MATRIX PROTEIN 22 FOR PREDICTION OF DISEASE RECURRENCE AND PROGRESSION IN PATIENTS WITH Ta, T1 OR CIS TRANSITIONAL CELL CARCINOMA OF THE BLADDER
148. randomized controlled trial evaluating the effect of low-dose chlormadinone in patients with low-risk prostate cancer: PROSAS study.
149. Should patients with localized prostate cancer receive primary androgen deprivation therapy?
150. Third Joint Meeting of the American Urological Association and the Japanese Urological Association International Program at the 103rd Annual Meeting of the American Urological Association at Orlando 2008
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.